3 - AmpC beta-lactamase: basics and clinical considerations

Speaker(s)

• 

  Nancy Hanson, PhD

  Professor
  Creighton University/Dept of Medical Microbiology and Immunology
  Omaha, Nebraska

  Disclosure: Streck : Grant/Research Support (Status: Ongoing), I have licensed patents with this company and this company has a product on the market regarding the detection of AmpC beta-lactamases. AmpC is the topic of my talk (Status: Ongoing), Other Financial or Material Support (Status: Ongoing)
• 

  Pranita Tamma, MD, MHS

  Associate Professor
  Johns Hopkins
  Baltimore, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-440-H01-P

Learning Objectives:

• describe how regulatory mechanisms of AmpC expression impact resistance phenotype
• review laboratory methods to detect AmpC production
• summarize available data on management of infection caused by AmpC producers

Presentations:

• 11:00am – 12:15pm EDT

  Ampc Beta-lactamase: Basics and Clinical Considerations - Speaker 1
  Nancy D. Hanson, PhD – Creighton University/Dept of Medical Microbiology and Immunology
• 11:00am – 12:15pm EDT

  Ampc Beta-lactamase: Basics and Clinical Considerations - Speaker 2
  Pranita Tamma, MD, MHS – Johns Hopkins